文献速递皮肤肿瘤

Fibulin-3在皮肤鳞状细胞癌中具有抗肿瘤活性

Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
PubMed 文献 · J Invest Dermatol · 2019-02-06

本研究探讨Fibulin-3在皮肤鳞状细胞癌(cSCC)中的作用。发现cSCC组织中Fibulin-3表达因启动子甲基化而下调;体外敲低促进增殖、抗凋亡及迁移侵袭,过表达则抑制增殖、诱导凋亡并减少迁移侵袭,与抑制AKT通路相关;小鼠移植瘤模型中过表达抑制肿瘤生长。提示Fibulin-3具抗肿瘤活性,可能成为治疗靶点。

要点

  • cSCC组织中Fibulin-3表达下调,与启动子甲基化相关。
  • 过表达Fibulin-3抑制cSCC细胞增殖、迁移侵袭并诱导凋亡。
  • Fibulin-3抗肿瘤效应与抑制AKT信号通路相关。

核心结论

  • Fibulin-3在cSCC中具有抗肿瘤活性,其下调参与cSCC发生发展,可能作为新的治疗靶点。

研究设计与样本

  • 研究比较cSCC组织与正常皮肤组织中Fibulin-3表达,并在cSCC细胞系A431和SCL-1中进行体外敲低和过表达实验,同时采用小鼠移植瘤模型验证体内效应。

主要发现

  • cSCC组织中Fibulin-3表达较正常皮肤组织下调,归因于Fibulin-3启动子甲基化。
  • 在A431和SCL-1细胞中敲低Fibulin-3促进细胞增殖、保护细胞免于凋亡并增强迁移和侵袭能力。
  • 过表达Fibulin-3通过促进G1/S期生长停滞抑制细胞增殖、诱导凋亡并降低迁移和侵袭能力。
  • Fibulin-3的抗癌效应与抑制AKT信号通路相关。
  • 小鼠移植瘤模型中过表达Fibulin-3抑制cSCC肿瘤体内生长。

临床怎么用

  • Fibulin-3下调与cSCC发展相关,过表达可抑制肿瘤生长,提示其可能作为cSCC的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Several previous studies have shown that fibulin-3 participates in the occurrence and development of various tumors; however, its role in cSCC remains unknown. In the present study, we observed that the expression of fibulin-3 was downregulated in cSCC tissues compared with normal skin tissues, which was due to fibulin-3 promoter methylation. In vitro, knockdown of fibulin-3 in cSCC cell lines A431 and SCL-1 cells promoted cell proliferation, protected cells against apoptosis and enhanced migration and invasion abilities. Conversely, overexpression of fibulin-3 inhibited cell proliferation by promoting growth arrest during the G1/S phase transition, induced apoptosis, and reduced migration and invasion abilities. These anticarcinogenic effects of fibulin-3 were associated with inhibition of the AKT signaling pathway. Through a mouse xenograft model, we found that fibulin-3 overexpression inhibited the cSCC tumor growth in vivo. Our results suggest that fibulin-3 has anti-tumorigenic activities in cSCC. Downregulation of fibulin-3 is involved in cSCC development and it may serve as a novel therapeutic target of this disease.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Wang X, Zhang Q, Li C, et al. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2019. PMID: 30738056. doi:10.1016/j.jid.2019.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。